6KFT
MVM NS2 mutant Nm42 in complex with CRM1-Ran-RanBP1
6KFT の概要
エントリーDOI | 10.2210/pdb6kft/pdb |
関連するPDBエントリー | 6A38 6A3A 6A3B 6A3C 6A3E |
分子名称 | GTP-binding nuclear protein Ran, Ran-specific GTPase-activating protein 1, Exportin-1, ... (10 entities in total) |
機能のキーワード | transport protein, nuclear export, complex, mutant, inhibitor |
由来する生物種 | Homo sapiens (Human) 詳細 |
タンパク質・核酸の鎖数 | 4 |
化学式量合計 | 160864.32 |
構造登録者 | |
主引用文献 | Sui, M.,Xiong, M.,Li, Y.,Zhou, Q.,Shen, X.,Jia, D.,Gou, M.,Sun, Q. Cancer Therapy with Nanoparticle-Medicated Intracellular Expression of Peptide CRM1-Inhibitor. Int J Nanomedicine, 16:2833-2847, 2021 Cited by PubMed Abstract: Peptides can be rationally designed as non-covalent inhibitors for molecularly targeted therapy. However, it remains challenging to efficiently deliver the peptides into the targeted cells, which often severely affects their therapeutic efficiency. PubMed: 33883894DOI: 10.2147/IJN.S266398 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.51 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード